Nytricx Inc is a cutting-edge biomedical company based in Athens, GA, specializing in the development of sustained release antimicrobial and antithrombotic nitric oxide (NO)-releasing medical devices. Their innovative technology, based on biocompatible NO-releasing biomaterials, aims to significantly reduce rates of infections and thrombotic events associated with medical devices, thereby enhancing their functional lifetime.
With a strong focus on translational research, Nytricx Inc utilizes a platform of novel chemistry, exemplified by their NORel nitric oxide (NO)-releasing polymers. By designing and implementing these advanced biomaterials, the company is at the forefront of combating medical device infection and thrombosis, offering promising solutions for improved patient outcomes in the field of healthcare.
Generated from the website